Tricho-dento-osseous
syndrome
The tricho-dento-osseous syndrome (TDO) (OMIM #190320) is an autosomal
dominant condition that derives its name from the three primarily
affected tissues including hair, teeth and bone.1 To date three large
kindreds and related families with TDO have been described in the
United States.2-4 In addition to these well documented kindreds that
are in geographic proximity (Washington County Virginia, Holston Valley
Tennessee and Alamance County North Carolina), there have been isolated
case reports of TDO from around the world.(1-6)
The Tissues Affected By TDO
Detailed clinical characterization of individuals with TDO (confirmed
DLX3 gene mutation) from multiple families show marked variability
in the hair, tooth and bone phenotype.
Hair: Hair abnormalities associated with TDO is
present in most but not all of the individuals having TDO. Kinky,
course and/or curly hair is present at birth in 80% of people with
TDO. Only 46% of the individuals with TDO and kinky, course and/or
curly hair at birth retain this phenotype after infancy.
| Enamel Hypoplasia:
Enamel hypoplasia and taurodontism is seen in 100% of the dentate
individuals with TDO. While all individuals with TDO appear
to have enamel hypoplasia and taurodontism, the expression of
these traits is highly variable. The teeth appear discolored
in 76% of the affected individuals while the remaining affected
individuals have teeth of normal color. Enamel alteration in
people with TDO ranges from being extremely thin and/or rough
and pitted (Figure 1) to being of normal color and only slightly
decreased thickness. |

Figure 1 |
Taurodontism: Taurodontism is an enlargement of
the pulp chamber in posterior teeth due to the apical displacement
of the furcation area that normally begins the separation of the
multiple root structures. The degree of taurodontism and the distribution
of teeth affected are highly variable. In some individuals there
is severe taurodontism of all the posterior teeth with the anterior
teeth showing enlarged pulp chambers (Figure 2). Both primary and
permanent teeth are typically affected. Mild expression of this
trait in a few affected individuals includes having little or no
evidence of taurodontism in the first permanent molars with the
second permanent molars showing pyramidal root morphology.

Figure2
Bone: Changes in the cranial bones
is observed in 93% of individuals with TDO. The majority of affected
family members display an increased cranial thickness, obliterated
diploë and no visible mastoid pneumatization. The loss of visible
mastoid pneumatization is the most common osseous feature seen in
affected individuals (82%) and is relatively uncommon in unaffected
people (8%). Skeletal manifestations can be seen in affected individuals
as young as 3 years of age. There is a trend for skeletal manifestations
to become more prevalent in older individuals. Diploë obliteration
appears to increase with age. However, 95% of people with TDO that
are 16 years of age or younger show some skeletal manifestations.
Figure 3 shows a normal cephalometric radiograph (a) with normal
bone density and the variably increased bone density in the heads
of two middle age females that have TDO.

Gene Defect That Causes TDO
Numerous homeobox genes are known to be expressed during craniofacial
development and are considered to be essential for normal morphological
development and patterning. The distal-less (DLX) homeobox genes
are expressed in both epithelial and mesenchymal craniofacial tissues
during embryogenesis.5, 6 The specific role of these genes in controlling
the complex growth and development pathways remains to be defined.
Analysis of multiple families in North Carolina and one large family
in Virginia revealed that the TDO phenotype was associated with
a four base pair deletion in the DLX3 homeobox gene.7-9 This deletion
results in a frameshift of the 3’ terminal portion of DLX3
and a termination codon at nucleotide 3398. The mutation results
in a DLX3 translation product that is 32 amino acids shorter than
the normal protein.
DLX3 DNA Sequence:
1 ATGAGCGGCT CCTTCGATCG CAAGCTCAGC
AGCATCCTCA CCGACATCTC CAGCTCGCTC
61 AGCTGCCATG CGGGCTCCAA GGACTCGCCC ACCCTGCCCG AATCTACAGT CACTGACCTG
121 GGCTATTACA GCGCTCCTCA GCATGACTAC TACTCGGGCC AGCCCTACGG CCAGACGGTG
181 AACCCCTACA CCTACCACCA CCAGTTCAAT CTCAATGGGC TCGCAGGCAC CGGCGCTTAC
241 TCGCCCAAGT CGGAATATAC CTACGGGGGA TCCTATAGGC AGTACGGAGC GTACCGGGAG
301 CAGCCTTTGC CTGCCCAGGA CCCAGTGTCG GTGAAAGAGG AGCCGGAAGC CGAGGTTCGC
361 ATGGTGAACG GCAAGCCCAA AAAGGTCCGA AAGCCGCGAA CGATCTACTC CAGCTATCAG
421 CTGGCTGCCC TGCAGCGCCG TTTCCAGAAA GCCCAGTATC TGGCCTTGCC
TGAGCGCGCC
481 GAGCTAGCTG CACAGCTGGG CCTCACACAA ACACAGGTGA AAATCTGGTT CCAGAACCGC
541 CGCTCCAAGT TCAAAAAGCT CTATAAGAAT
GGGGAGGTGC CGCTGGAACA CAGCCCCAAC
601 AACAGTGACT CCATGGCCTG CAACTCACCG CCGTCACCAG CACTCTGGGA CACATCTTCC
661 CATTCCACGC CAGCCCCTGC CCGCAATCCG CTGCCCCCAC CGCTCCCATA CAGTGCCTCC
721 CCCAACTACC TGGACGACCC CACCAACTCC TGGTACCACA CACAGAACCT CAGTGGACCC
781 CACTTACAGC AGCAGCCTCC TCAGCCGGCT ACCCTGCACC ATGCCTCCCC TGGGCCCCCG
841 CCTAACCCTG GGGCTGTGTA CTGAGTACCC ACCTGGCCTG CGCCCCTCCA CGAAGGACCC
901 CCTCCAGGAC CAGGCAGAAG GTGCCCTGTC CTAGCGACAC TCAGGAATCA TTGAGGGGCA
961 CAGGGGGAAA GACTCCCTTC CCTCTCCCTT GTCCCTTCTT CCAGGGGCCC AACAACCTCC
1021 AGATGACAAA TGCATGGACC GAGGATGCCC CCCAATCTCC CTCCCCTTGC TTAGACTGGG
1081 GTGCCCTCCA GACGGCGAGG AGTTCTACCC CAGTGGGGAC AGCACATGCT CTCTGCTCCA
1141 GGAACCCGGA TTGCCTCTAG ATGGCTCATC ACTTTCCAGC TTTTCAAACA CAGTAGAGAC
1201 CTCCAAAATG GGAGCCAGAG TGTTTGCAGG TCCACCTGTG CTGGGGCACC AGGCGCCACG
1261 GATTCCAGCA CAGCCAGACC TAAAGCACCA AGCCG
Fig 1. cDNA sequence of Dlx3 (3). The homeobox sequence is underlined.
The four base pair deletion in TDO patients is highlighted. The
amplification sequence from RT-PCR should be of 379 base pair segment.
Research
The TDO syndrome was first recognized in 1966 by Robinson and was
given its present name by Lichtenstein in 1970. We began our clinical
investigation of families with TDO in 1993 through support from
the National Institute of Dental and Craniofacial Research. Investigation
of large families with TDO led to identification of the trait loci
at Chromosome 17q21 and in 1998 identification of the DLX3 gene
mutation.8
We are continuing research at both the molecular level to characterize
the role of DLX3 in hair, tooth and bone formation and at the clinical
level. Clinical studies are currently underway to better define
the variability in the hair, tooth and bone manifestations and to
identify genes (other than DLX3) that are affecting the TDO phenotype.
TDO Treatment
There are no known pathological problems associated with the hair
or bone changes seen in people with TDO caused by the 4 base pair
deletion mutation in the DLX3 gene. The dental manifestations can
be quite severe resulting in dental abscess formation and in many
older patients premature tooth loss. Dental abscess formation appears
to result from pulp exposures that occur when the thin enamel covering
is worn through allowing the enlarged pulp chambers to be exposed
directly to the oral cavity.
Individuals affected with TDO that have very thin enamel can benefit
from covering the teeth with a bonded filled composite resin to
help prevent exposure of pulp horns through wear. The enamel that
is present is typically well mineralized and generally retains bonded
materials adequately.
Reshaping of small anterior teeth in the primary or young permanent
dentitions can often be accomplished using bonding techniques. In
more severe cases the anterior and posterior teeth may require full
coverage crowns to protect them and prevent abscess formation. It
has been our experience that permanent teeth with
|